Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

News Daily News

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

December 28, 2021

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

December 27, 2021

Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis

News Daily News

Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis

December 16, 2021

TCTMD’s Top 10 Most Popular Stories for November 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

November 30, 2021

Cardiologist Robert Califf Nominated to Head FDA—Again

News Daily News

Cardiologist Robert Califf Nominated to Head FDA—Again

November 12, 2021

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

News Daily News

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

October 28, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

October 11, 2021

Title (ideally under 60 characters) DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

September 15, 2021

Long-term Anticoagulation After Unprovoked VTE: New Insights

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

September 13, 2021

Could an App Replace Statin Prescribing by Doctors?

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

News Daily News

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

August 20, 2021

FDA Approves Amplatzer Amulet LAA Occluder

News Daily News

FDA Approves Amplatzer Amulet LAA Occluder

August 17, 2021

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

News Daily News

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

Michael O'Riordan

August 17, 2021

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

August 10, 2021

Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI

News Daily News

Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI

August 10, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 2

August 08, 2021

COVID-19: TCTMD’s Daily Dispatch for July Week 4

News Daily News

COVID-19: TCTMD’s Daily Dispatch for July Week 4

July 26, 2021

Apixaban May Be Best DOAC for Frail, Older Patients With AF

News Daily News

Apixaban May Be Best DOAC for Frail, Older Patients With AF

July 19, 2021

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.